Amiodarone (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Amiodarone" in Italian language version.

refsWebsite

Global rank Italian rank

11nih.gov

4^th place

9^th place

8doi.org

2^nd place

7^th place

5archive.org

6^th place

8^th place

3oadoi.org

799^th place

22^nd place

2web.archive.org

1^st place

2amjmed.com

low place

1fda.gov

447^th place

644^th place

1vincenzopiazza.it

low place

1worldcat.org

5^th place

26^th place

1unibo.it

4,963^rd place

325^th place

1bnf.org

low place

amjmed.com

Batcher EL, Tang XC, Singh BN, Singh SN, Reda DJ, Hershman JM, Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation, in Am J Med, vol. 120, n. 10, ottobre 2007, pp. 880–85, DOI:10.1016/j.amjmed.2007.04.022.
Batcher EL, Tang XC, Singh BN, Singh SN, Reda DJ, Hershman JM, Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation, in Am J Med, vol. 120, n. 10, ottobre 2007, pp. 880-85, DOI:10.1016/j.amjmed.2007.04.022.

archive.org

Singh BN, Vaughan Williams EM, The effect of amiodarone, a new anti-anginal drug, on cardiac muscle, in Br. J. Pharmacol., vol. 39, n. 4, 1970, pp. 657-67, PMID 5485142.
Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR, Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial, in J. Am. Coll. Cardiol., vol. 34, n. 2, 1999, pp. 343–7, DOI:10.1016/S0735-1097(99)00212-0, PMID 10440143.
Flaharty KK, Chase SL, Yaghsezian HM, Rubin R, Hepatotoxicity associated with amiodarone therapy, in Pharmacotherapy, vol. 9, n. 1, 1989, pp. 39–44, PMID 2646621.
Singhal A, Ghosh P, Khan SA, Low dose amiodarone causing pseudo-alcoholic cirrhosis, in Age and ageing, vol. 32, n. 2, 2003, pp. 224–5, DOI:10.1093/ageing/32.2.224, PMID 12615569.
Puli SR, Fraley MA, Puli V, Kuperman AB, Alpert MA, Hepatic cirrhosis caused by low-dose oral amiodarone therapy, in Am. J. Med. Sci., vol. 330, n. 5, 2005, pp. 257–61, DOI:10.1097/00000441-200511000-00012, PMID 16284489.

bnf.org

British National Formulary Guida al monitoraggio della funzione tiroidea (BNF Amiodarone)

doi.org

dx.doi.org

Rosenbaum MB, Chiale PA, Halpern MS, et al., Clinical efficacy of amiodarone as an antiarrhythmic agent, in Am. J. Cardiol., vol. 38, n. 7, 1976, pp. 934-44, DOI:10.1016/0002-9149(76)90807-9, PMID 793369.
Rosenbaum MB, Chiale PA, Haedo A, Lázzari JO, Elizari MV, Ten years of experience with amiodarone, in Am. Heart J., vol. 106, 4 Pt 2, 1983, pp. 957-64, DOI:10.1016/0002-8703(83)90022-4, PMID 6613843.
Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR, Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial, in J. Am. Coll. Cardiol., vol. 34, n. 2, 1999, pp. 343–7, DOI:10.1016/S0735-1097(99)00212-0, PMID 10440143.
Angela Lombardi, William Barlow Inabnet, Randall Owen, Kaitlyn Ellen Farenholtz e Yaron Tomer, Endoplasmic Reticulum Stress as a Novel Mechanism in Amiodarone-Induced Destructive Thyroiditis, in The Journal of Clinical Endocrinology & Metabolism, vol. 100, n. 1, 2015, pp. E1–E10, DOI:10.1210/jc.2014-2745, ISSN 0021-972X (WC · ACNP).
Batcher EL, Tang XC, Singh BN, Singh SN, Reda DJ, Hershman JM, Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation, in Am J Med, vol. 120, n. 10, ottobre 2007, pp. 880–85, DOI:10.1016/j.amjmed.2007.04.022.
Batcher EL, Tang XC, Singh BN, Singh SN, Reda DJ, Hershman JM, Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation, in Am J Med, vol. 120, n. 10, ottobre 2007, pp. 880-85, DOI:10.1016/j.amjmed.2007.04.022.
Singhal A, Ghosh P, Khan SA, Low dose amiodarone causing pseudo-alcoholic cirrhosis, in Age and ageing, vol. 32, n. 2, 2003, pp. 224–5, DOI:10.1093/ageing/32.2.224, PMID 12615569.
Puli SR, Fraley MA, Puli V, Kuperman AB, Alpert MA, Hepatic cirrhosis caused by low-dose oral amiodarone therapy, in Am. J. Med. Sci., vol. 330, n. 5, 2005, pp. 257–61, DOI:10.1097/00000441-200511000-00012, PMID 16284489.

fda.gov

Drug Approval Package, su fda.gov. URL consultato il 30 settembre 2007.

nih.gov

ncbi.nlm.nih.gov

(FR) Deltour G, Binon F, Tondeur R, et al., [Studies in the benzofuran series. VI. Coronary-dilating activity of alkylated and aminoalkylated derivatives of 3-benzoylbenzofuran.], in Archives internationales de pharmacodynamie et de thérapie, vol. 139, 1962, pp. 247-54, PMID 14026835.
(FR) Charlier R, Deltour G, Tondeur R, Binon F, [Studies in the benzofuran series. VII. Preliminary pharmacological study of 2-butyl-3-(3,5-diiodo-4-beta-N-diethylaminoethoxybenzoyl)-benzofuran.], in Archives internationales de pharmacodynamie et de thérapie, vol. 139, 1962, pp. 255-64, PMID 14020244.
Singh BN, Vaughan Williams EM, The effect of amiodarone, a new anti-anginal drug, on cardiac muscle, in Br. J. Pharmacol., vol. 39, n. 4, 1970, pp. 657-67, PMID 5485142.
Rosenbaum MB, Chiale PA, Halpern MS, et al., Clinical efficacy of amiodarone as an antiarrhythmic agent, in Am. J. Cardiol., vol. 38, n. 7, 1976, pp. 934-44, DOI:10.1016/0002-9149(76)90807-9, PMID 793369.
Rosenbaum MB, Chiale PA, Haedo A, Lázzari JO, Elizari MV, Ten years of experience with amiodarone, in Am. Heart J., vol. 106, 4 Pt 2, 1983, pp. 957-64, DOI:10.1016/0002-8703(83)90022-4, PMID 6613843.
Siddoway LA, Amiodarone: guidelines for use and monitoring, in American family physician, vol. 68, n. 11, 2003, pp. 2189–96, PMID 14677664. URL consultato il 29 maggio 2009 (archiviato dall'url originale il 15 maggio 2008).
Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR, Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial, in J. Am. Coll. Cardiol., vol. 34, n. 2, 1999, pp. 343–7, DOI:10.1016/S0735-1097(99)00212-0, PMID 10440143.
Siddoway LA, Amiodarone: guidelines for use and monitoring, in American family physician, vol. 68, n. 11, 2003, pp. 2189-96, PMID 14677664. URL consultato il 29 maggio 2009 (archiviato dall'url originale il 15 maggio 2008).
Flaharty KK, Chase SL, Yaghsezian HM, Rubin R, Hepatotoxicity associated with amiodarone therapy, in Pharmacotherapy, vol. 9, n. 1, 1989, pp. 39–44, PMID 2646621.
Singhal A, Ghosh P, Khan SA, Low dose amiodarone causing pseudo-alcoholic cirrhosis, in Age and ageing, vol. 32, n. 2, 2003, pp. 224–5, DOI:10.1093/ageing/32.2.224, PMID 12615569.
Puli SR, Fraley MA, Puli V, Kuperman AB, Alpert MA, Hepatic cirrhosis caused by low-dose oral amiodarone therapy, in Am. J. Med. Sci., vol. 330, n. 5, 2005, pp. 257–61, DOI:10.1097/00000441-200511000-00012, PMID 16284489.

oadoi.org

Rosenbaum MB, Chiale PA, Halpern MS, et al., Clinical efficacy of amiodarone as an antiarrhythmic agent, in Am. J. Cardiol., vol. 38, n. 7, 1976, pp. 934-44, DOI:10.1016/0002-9149(76)90807-9, PMID 793369.
Rosenbaum MB, Chiale PA, Haedo A, Lázzari JO, Elizari MV, Ten years of experience with amiodarone, in Am. Heart J., vol. 106, 4 Pt 2, 1983, pp. 957-64, DOI:10.1016/0002-8703(83)90022-4, PMID 6613843.
Angela Lombardi, William Barlow Inabnet, Randall Owen, Kaitlyn Ellen Farenholtz e Yaron Tomer, Endoplasmic Reticulum Stress as a Novel Mechanism in Amiodarone-Induced Destructive Thyroiditis, in The Journal of Clinical Endocrinology & Metabolism, vol. 100, n. 1, 2015, pp. E1–E10, DOI:10.1210/jc.2014-2745, ISSN 0021-972X (WC · ACNP).

unibo.it

acnpsearch.unibo.it

Angela Lombardi, William Barlow Inabnet, Randall Owen, Kaitlyn Ellen Farenholtz e Yaron Tomer, Endoplasmic Reticulum Stress as a Novel Mechanism in Amiodarone-Induced Destructive Thyroiditis, in The Journal of Clinical Endocrinology & Metabolism, vol. 100, n. 1, 2015, pp. E1–E10, DOI:10.1210/jc.2014-2745, ISSN 0021-972X (WC · ACNP).

vincenzopiazza.it

Amiodarone e tiroide

web.archive.org

Siddoway LA, Amiodarone: guidelines for use and monitoring, in American family physician, vol. 68, n. 11, 2003, pp. 2189–96, PMID 14677664. URL consultato il 29 maggio 2009 (archiviato dall'url originale il 15 maggio 2008).
Siddoway LA, Amiodarone: guidelines for use and monitoring, in American family physician, vol. 68, n. 11, 2003, pp. 2189-96, PMID 14677664. URL consultato il 29 maggio 2009 (archiviato dall'url originale il 15 maggio 2008).

worldcat.org

Angela Lombardi, William Barlow Inabnet, Randall Owen, Kaitlyn Ellen Farenholtz e Yaron Tomer, Endoplasmic Reticulum Stress as a Novel Mechanism in Amiodarone-Induced Destructive Thyroiditis, in The Journal of Clinical Endocrinology & Metabolism, vol. 100, n. 1, 2015, pp. E1–E10, DOI:10.1210/jc.2014-2745, ISSN 0021-972X (WC · ACNP).